London, May 23, 2023 (GLOBE NEWSWIRE) -- The remarkably growing preference for minimally invasive biopsy procedures is predominantly driving the expansion of the global smart biopsy devices market valuation. The advent of cancer diagnostics, oncology research advancements, and an increasing number of awareness initiatives will continue to be the collective driving factors for the market, says a new study of Fairfield Market Research on the global smart biopsy devices space.
Get Sample Copy/TOC of Smart Biopsy Devices Market: https://www.fairfieldmarketresearch.com/report/smart-biopsy-devices-market/request-toc
Insights into Segmentation Analysis
Breast cancer, the highest prevalence type of cancer in the world, generates the maximum demand for early diagnosis, in turn the instruments like smart biopsy devices. The rates of diagnosis of invasive and non-invasive breast cancers have been alarming, recently, creating a continuous stream of business opportunities for manufacturers of smart biopsy devices. A consistently escalating number of mammography tests is also expected to fuel the significant of this segment in the market during long run.
Breast cancer will most likely be the fastest-growing market segment and in line with this, the demand for biopsy devices is likely to see a spike across the low- and middle-income countries where the prevalence is growing rapidly. However, the relatively low awareness regarding symptoms, and non-affordability of diagnostics in most areas may continue to challenge the pace of market growth. Skin cancer is also identified as an important segment of the market.
Insights into Regional Analysis
The number of cancer patients has been constantly on the rise and North America remains at the forefront. The US especially houses the strongest breeding ground for cancer research, diagnosis, treatment, and R&D initiatives. The nation benefits significantly from the strong presence of some of the globally leading industry players. North America’s smart biopsy devices market is expected to continue to be at the forefront of demand generation as the number of cancer cases remains the highest, the governments are supportive through various awareness initiatives, and the availability of oncology research funding is higher.
The prevalence of breast cancer particularly registers the highest rate across the region, which drives some of the world’s largest breast cancer charities. This will continue to account for the accelerated growth of North America’s smart biopsy devices market in long term. Increasing funding scenario in the private sector is also likely to add value to the market performance here. The other factors contributing toward market growth in the region include higher healthcare spending, favorable reimbursement scenario, and wider availability of advanced technology-enabled smart biopsy devices.
Do You Have Any Query or Specific Requirement? Request for Custom Research: https://www.fairfieldmarketresearch.com/report/smart-biopsy-devices-market/request-customization
Key Companies in Global Smart Biopsy Devices Market
B. Braun Melsungen AG, Danaher, Cook Medical, Argon Medical, Becton, Dickinson and Company, Boston Scientific Corporation, Canon Medical Systems Corporation, C. R. Bard, IMS Giotto S.p.A, INRAD, Inc., PLANMED OY, and Intuitive Surgical represent some of the leaders in the global
Global Smart Biopsy Devices Market is Segmented as Below:
By Application
- Breast Cancer
- Liver Cancer
- Skin Cancer
- Prostate Cancer
- Others
By End User
- Hospitals
- Academic and Research Institutes
- Diagnostic and Imaging Centres
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- France
- Germany
- Russia
- Rest of Europe
- Asia Pacific
- Japan
- South Korea
- India
- China
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
Key Elements Included In The Study: Global Smart Biopsy Devices Market
- Smart Biopsy Devices Market by Product/Technology/Grade, Application/End-user, and Region
- Executive Summary (Opportunity Analysis and Key Trends)
- Historical Market Size and Estimates, Value, 2018 - 2021
- Market Value at Regional and Country Level, 2022 - 2029
- Market Dynamics and Economic Overview
- Market Size in Value, Growth Rates, and Forecast Figures, 2022 - 2029
- Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies
- Regional and Product/Grade/Application/End-user Price Trends Analysis
- Value Chain and Five Force’s Analysis
- Regional/Sub-region/Country Market Size and Trend Analysis
- Company Market Share Analysis and Key Player Profiles
Learn More About the Report Inclusions, and Research Methodology: https://www.fairfieldmarketresearch.com/report/smart-biopsy-devices-market/more-information
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
Twitter: https://twitter.com/FairfieldMarket
LinkedIn: https://www.linkedin.com/company/fairfield-market-research-uk
